NIHR i4i & OLS Real World Evidence Programme briefing
Posted:
The NIHR i4i Programme, in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), invites applications to the NIHR i4i & OLS Real World Evidence Programme.
An online launch event will be held 10:30am-12pm on Tuesday 23 January, please register via eventbrite to attend.
The Bacillus Calmette-Guérin (BCG) vaccine prevents severe forms of tuberculosis (TB) and is the world’s most widely used vaccine, as well as the oldest vaccine still in use.
Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us